.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent clinical investigations have highlighted epicardial adipose tissue volume as a pivotal biomarker for assessing cardiorenal risk in patients with hypertension. Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot located between the myocardium and the pericardium. While both EAT volume and density are measurable via computerized tomography, current evidence suggests that volume offers superior predictive value. Research published in 2026 clarifies how these adiposity markers influence heart and kidney health in hypertensive populations.
The study compared 156 hypertensive individuals with 101 healthy controls using coronary computerized tomography angiography. Specifically, patients with hypertension demonstrated significantly higher epicardial adipose tissue volume compared to their normotensive counterparts. In contrast, researchers observed no substantial difference in EAT density between the two groups. Statistical analyses revealed that EAT volume correlates strongly with critical markers such as left ventricular mass index and the Renin-Angiotensin System Index. Consequently, these findings indicate that the quantity of fat surrounding the heart directly impacts structural cardiac changes.
Mediation analysis further illustrates the complex relationship between hypertension and cardiorenal dysfunction. Epicardial adipose tissue volume acts as a significant mediator, bridging the gap between elevated blood pressure and end-organ damage. Moreover, managing EAT through lifestyle or pharmacological interventions could potentially mitigate the risk of heart failure. Clinicians should consider EAT volume as a standard metric in cardiac imaging for hypertensive patients to refine risk stratification.
Furthermore, the data suggests that the association of EAT volume with complications remains robust after adjusting for traditional risk factors. This independence confirms that localized adiposity exerts unique paracrine effects on the heart and kidneys. Therefore, prioritizing volume measurements over density provides a more accurate reflection of a patient's clinical trajectory. However, further longitudinal studies are needed to confirm these causal pathways in diverse populations.
High EAT volume releases proinflammatory cytokines directly into the myocardium. This paracrine activity leads to structural remodeling, such as left ventricular hypertrophy and myocardial fibrosis, which are common in hypertensive patients.
While EAT density reflects the metabolic state of the tissue, EAT volume represents the total burden of visceral fat. In hypertensive patients, the absolute amount of fat appears more closely linked to mechanical and hormonal complications.
Yes, intensive lifestyle modifications and certain medications, such as SGLT2 inhibitors, have shown promise in reducing EAT volume. Lowering this fat depot may help decrease the risk of cardiorenal complications over time.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship between the reader and the author. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Wu HX et al. Epicardial adipose tissue volume outperforms density in association with cardiorenal complications in hypertensive patients. Lipids Health Dis. 2026 Feb 12. doi: 10.1186/s12944-026-02873-x. PMID: 41673673.
Iacobellis G. Epicardial adipose tissue: from radiology to clinical practice. Nat Rev Endocrinol. 2022;18(10):593-605.
Bertaso AG, Bertol D, Duncan BB, Foppa M. Epicardial Fat: Review of Proper Measurement and Clinical Significance. Arq Bras Cardiol. 2013;101(1):88-95.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study highlights that epicardial adipose tissue volume, rather than density, is a primary marker for cardiorenal complications in hypertensive patients....
6 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
